Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Apogee Therapeutics, Inc. APGE | RTW Investments, LP | 2,712,097 6.000% | 2,712,097 (New Position) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | RTW Investments, LP | 3,621,996 6.200% | 1,389,236 (+62.22%) | Filing History |
| 2025-01-29 4:10 pm Sale | 2025-01-28 | 13D | Allurion Technologies Inc. ALUR | RTW Investments, LP | 1,050,053 21.900% | -7 (-0.00%) | Filing History |
| 2025-01-16 8:22 pm Purchase | 2025-01-14 | 13D | Allurion Technologies Inc. ALUR | RTW Investments, LP | 1,050,060 29.600% | 772,263 (+278.00%) | Filing History |
| 2025-01-10 7:39 pm Purchase | 2025-01-07 | 13D | Allurion Technologies Inc. ALUR | RTW Investments, LP | 277,797 9.990% | 277,797 (New Position) | Filing History |
| 2024-12-16 7:51 pm Purchase | 2024-12-12 | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW Investments, LP | 18,401,313 17.600% | 212,856 (+1.17%) | Filing History |
| 2024-11-14 07:00 am Sale | 2024-09-30 | 13G | Arvinas, Inc. ARVN | RTW Investments, LP | 2,782,329 4.100% | -1,431,154 (-33.97%) | Filing History |
| 2024-11-14 06:58 am Purchase | 2024-09-30 | 13G | Immunic, Inc. IMUX | RTW Investments, LP | 5,594,479 6.100% | 1,259,224 (+29.05%) | Filing History |
| 2024-11-14 06:56 am Purchase | 2024-09-30 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 3,261,496 7.400% | 962,834 (+41.89%) | Filing History |
| 2024-11-14 06:53 am Purchase | 2024-09-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX | RTW Investments, LP | 5,941,456 9.990% | 765,624 (+14.79%) | Filing History |
| 2024-11-14 06:51 am Purchase | 2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO | RTW Investments, LP | 5,919,435 8.500% | 2,326,676 (+64.76%) | Filing History |
| 2024-11-14 06:48 am Purchase | 2024-09-30 | 13G | ACADIA Pharmaceuticals Inc. ACAD | RTW Investments, LP | 13,707,506 8.300% | 2,453,955 (+21.81%) | Filing History |
| 2024-11-14 06:46 am Purchase | 2024-09-30 | 13G | 89bio, Inc. ETNB | RTW Investments, LP | 7,378,548 7.000% | 1,799,617 (+32.26%) | Filing History |
| 2024-11-14 06:44 am Purchase | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | RTW Investments, LP | 4,930,204 9.990% | 3,203,396 (+185.51%) | Filing History |
| 2024-11-14 06:42 am Sale | 2024-09-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW Investments, LP | 1,968,002 2.100% | -4,919,084 (-71.42%) | Filing History |
| 2024-11-14 06:40 am Sale | 2024-09-30 | 13G | Immunocore Holdings plc IMCR | RTW Investments, LP | 4,869,798 9.700% | -1,226,589 (-20.12%) | Filing History |
| 2024-11-14 06:37 am Purchase | 2024-09-30 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC | RTW Investments, LP | 742,500 8.300% | 742,500 (New Position) | Filing History |
| 2024-11-14 06:34 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | RTW Investments, LP | 6,818,641 6.800% | 6,818,641 (New Position) | Filing History |
| 2024-11-14 06:32 am Purchase | 2024-09-30 | 13G | Immatics N.V. IMTX | RTW Investments, LP | 10,000,000 9.700% | 10,000,000 (New Position) | Filing History |
| 2024-11-14 06:30 am Purchase | 2024-09-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | RTW Investments, LP | 1,993,687 9.200% | 1,993,687 (New Position) | Filing History |